People Who Get Johnson & Johnson Vaccine at Elevated Risk of Guillain-Barré Syndrome: Study

People Who Get Johnson & Johnson Vaccine at Elevated Risk of Guillain-Barré Syndrome: Study
Syringes with doses of the Johnson & Johnson COVID-19 vaccine are seen in California in a file photograph. Patrick T. Fallon/AFP via Getty Images
Zachary Stieber
By Zachary Stieber, Senior Reporter
Updated:

People who receive the Johnson & Johnson COVID-19 vaccine are at elevated risk of getting a severe autoimmune disorder that can cause paralysis, according to a new study.

Researchers used data from the Vaccine Safety Datalink, which is run by the Centers for Disease Control and Prevention (CDC). They found (pdf) 21 potential cases, 11 of which were confirmed, of Guillain-Barré syndrome (GBS) in people who got the shot. Most happened with 13 days of vaccination.
Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics